Page last updated: 2024-08-21

alpha-aminopyridine and Candidiasis, Invasive

alpha-aminopyridine has been researched along with Candidiasis, Invasive in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bocanegra, R; Duncanson, FP; Everson, MP; Fothergill, AW; Kirkpatrick, WR; McCarthy, DI; Najvar, LK; Olivo, M; Patterson, TF; Wiederhold, NP1

Other Studies

1 other study(ies) available for alpha-aminopyridine and Candidiasis, Invasive

ArticleYear
The investigational agent E1210 is effective in treatment of experimental invasive candidiasis caused by resistant Candida albicans.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:1

    Topics: Aminopyridines; Animals; Antifungal Agents; Candida albicans; Candidiasis, Invasive; Caspofungin; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Echinocandins; Fluconazole; Isoxazoles; Lipopeptides; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests

2015